Stock Analysis·← Pickers

WST

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 64.4, with 3/3 trend checks passing.

Price
$359.00
2026-07-16
Trend score
3/3
Uptrend
RSI (14)
64.4
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

WST with MA50 and MA200

365.7330.1294.5258.9223.307/3110/2401/2204/1707/15
WST2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$329.35+9.00% vs price
MA200
$280.04+28.19% vs price
RSI (14)
64.4Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for WST

West Pharmaceutical Services, Inc. (WST) is still trading in a constructive trend overall. The latest available price is $359.00, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 9.0% and above the 200-day moving average by 28.2%.

Momentum and stretch context

WST currently has an RSI reading of 64.4, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

For traders reviewing WST next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green
Employees
10,800
Market cap
$25.36B
Beta
1.16
52-week range
$206.80 – $367.66
Dividend
Yes · $0.87
Exchange
NYSE
Country
US
IPO date
17 Mar 1980
ISIN
US9553061055
CUSIP
955306105
Company profile data from Financial Modeling Prep. WST listed on NYSE.
Share dilution

WST shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
72.0M
Since Jun 2019
-2.3%
Trend
Fewer shares outstanding (buybacks)
Historical shares-outstanding data from Financial Modeling Prep. WST28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about WST

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.